Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 26;13(28):19243-19256.
doi: 10.1039/d3ra01790g. eCollection 2023 Jun 22.

Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides

Affiliations

Synthesis, ADMT prediction, and in vitro and in silico α-glucosidase inhibition evaluations of new quinoline-quinazolinone-thioacetamides

Sajedeh Safapoor et al. RSC Adv. .

Abstract

In this work, a new series of quinoline-quinazolinone-thioacetamide derivatives 9a-p were designed using a combination of effective pharmacophores of the potent α-glucosidase inhibitors. These compounds were synthesized by simple chemical reactions and evaluated for their anti-α-glucosidase activity. Among the tested compounds, compounds 9a, 9f, 9g, 9j, 9k, and 9m demonstrated significant inhibition effects in comparison to the positive control acarbose. Particularly, compound 9g with inhibitory activity around 83-fold more than acarbose exhibited the best anti-α-glucosidase activity. Compound 9g showed a competitive type of inhibition in the kinetic study, and the molecular simulation studies demonstrated that this compound with a favorable binding energy occupied the active site of α-glucosidase. Furthermore, in silico ADMET studies of the most potent compounds 9g, 9a, and 9f were performed to predict their drug-likeness, pharmacokinetic, and toxicity properties.

PubMed Disclaimer

Conflict of interest statement

All the authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Design strategy for the new designed compounds as the potent α-glucosidase inhibitors.
Scheme 1
Scheme 1. Synthesis pathway of compounds 9a–p.
Scheme 2
Scheme 2. Anti-α-glucosidase activity of acridine–thioacetamides C and their corresponding analogs of the new quinoline–quinazolinone–thioacetamide derivatives 9.
Scheme 3
Scheme 3. Comparison of α-glucosidase inhibitory activity of benzimidazole derivatives D with their corresponding analogs of the newly synthesized quinazolinone derivatives 9.
Fig. 2
Fig. 2. Inhibitory kinetics of compound 9g on α-glucosidase. (a) Lineweaver–Burk plots for inhibition of compound 9g. (b) The secondary plot of Lineweaver–Burk plots for determination Ki value of compound 9g.
Fig. 3
Fig. 3. 3D and 2D interaction modes of the most potent compounds 9g and 9a in the active site of α-glucosidase.
Fig. 4
Fig. 4. 3D and 2D interaction modes of the most potent compounds 9f and 9k in the active site of α-glucosidase.
Fig. 5
Fig. 5. Superimposed RMSD of Cα atoms of α-glucosidase in complex with 9g (red) and acarbose (indigo).
Fig. 6
Fig. 6. Superimposed RMSD of 9g (red) and acarbose (indigo) in complex with α-glucosidase.
Fig. 7
Fig. 7. (A) RMSF graph of the Cα atoms of α-glucosidase in complex with acarbose (indigo) and 9g (red). (B) Close-up representation of α-glucosidase active site.
Fig. 8
Fig. 8. RMSF graph of the heavy atoms of 9g (A) and acarbose (B) in complex with α-glucosidase. Structure of these compounds and parts of these molecules with greatest fluctuations are illustrated.
Fig. 9
Fig. 9. Time dependence of the radius of gyration (Rg) graph of α-glucosidase in complex with 9g (red) and acarbose (indigo).

References

    1. Choi C. W. Choi Y. H. Cha M. R. Yoo D. S. Kim Y. S. Yon G. H. Hong K. S. Kim Y. H. Ryu S. Y. J. Agric. Food Chem. 2010;58:9988–9993. - PubMed
    1. Israili Z. H. Am. J. Ther. 2011;18:117–152. - PubMed
    1. Humphries M. J. Matsumoto K. White S. L. Olden K. Cancer Res. 1986;46:5215. - PubMed
    1. Karpas A. Fleet G. W. Dwek R. A. Petursson S. Namgoong S. K. Ramsden N. G. Jacob G. S. Rademacher T. W. Proc. Natl. Acad. Sci. U. S. A. 1998;85:9229–9233. - PMC - PubMed
    1. Roig-Zamboni V. Cobucci-Ponzano B. Iacono R. Ferrara M. C. Germany S. Bourne Y. Parenti G. Moracci M. Sulzenbacher G. Nat. Commun. 2017;8:1111. - PMC - PubMed